Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

PPCBD

Propanc Biopharma (PK) (PPCBD)

Propanc Biopharma Inc (PK)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:PPCBD
DateTimeSourceHeadlineSymbolCompany
07/02/20241:29PMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:PPCBDPropanc Biopharma Inc (PK)
06/21/20248:59AMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:PPCBDPropanc Biopharma Inc (PK)
06/13/20246:10AMEdgar (US Regulatory)Form 8-K/A - Current report: [Amend]USOTC:PPCBDPropanc Biopharma Inc (PK)
06/12/20246:01AMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:PPCBDPropanc Biopharma Inc (PK)
06/05/20246:05AMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:PPCBDPropanc Biopharma Inc (PK)
05/16/20246:05AMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:PPCBDPropanc Biopharma Inc (PK)
05/15/20244:38PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:PPCBDPropanc Biopharma Inc (PK)
04/22/202412:12PMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:PPCBDPropanc Biopharma Inc (PK)
04/10/20244:20PMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:PPCBDPropanc Biopharma Inc (PK)
03/11/20243:15PMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:PPCBDPropanc Biopharma Inc (PK)
02/20/20242:39PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:PPCBDPropanc Biopharma Inc (PK)
02/14/20242:47PMEdgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:PPCBDPropanc Biopharma Inc (PK)
12/15/20233:57PMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:PPCBDPropanc Biopharma Inc (PK)
12/07/20234:18PMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:PPCBDPropanc Biopharma Inc (PK)
11/14/20233:03PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:PPCBDPropanc Biopharma Inc (PK)
11/03/20234:05PMEdgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesUSOTC:PPCBDPropanc Biopharma Inc (PK)
10/30/20234:05PMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:PPCBDPropanc Biopharma Inc (PK)
10/26/20234:42PMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:PPCBDPropanc Biopharma Inc (PK)
10/26/20234:07PMEdgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesUSOTC:PPCBDPropanc Biopharma Inc (PK)
10/13/202312:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessUSOTC:PPCBDPropanc Biopharma Inc (PK)
10/06/20235:26PMEdgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]USOTC:PPCBDPropanc Biopharma Inc (PK)
09/28/20234:16PMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]USOTC:PPCBDPropanc Biopharma Inc (PK)
08/31/20234:08PMEdgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesUSOTC:PPCBDPropanc Biopharma Inc (PK)
08/31/20234:06PMEdgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesUSOTC:PPCBDPropanc Biopharma Inc (PK)
08/30/20234:05PMEdgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesUSOTC:PPCBDPropanc Biopharma Inc (PK)
08/29/20236:04AMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:PPCBDPropanc Biopharma Inc (PK)
08/23/20234:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PPCBDPropanc Biopharma Inc (PK)
08/21/20235:25PMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:PPCBDPropanc Biopharma Inc (PK)
08/21/20235:25PMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:PPCBDPropanc Biopharma Inc (PK)
08/16/20234:39PMEdgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesUSOTC:PPCBDPropanc Biopharma Inc (PK)
 Showing the most relevant articles for your search:USOTC:PPCBD